Header cover image

Brazilian Pharmaceuticals & Biotech Price disconnect

Results

2

1 new

Stocks which the market has priced substantially different to their cash flows, which could imply risk.

2 companies

Hypera

Market Cap: R$14.8b

Operates as a pharmaceutical company in Brazil.

HYPE3

R$20.98

7D

-0.9%

1Y

-9.4%

Ouro Fino Saúde Animal Participações

Market Cap: R$1.3b

Engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil.

New

OFSA3

R$24.70

7D

-6.3%

1Y

12.2%